Cargando…
T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual
Immunocompromised individuals are at higher risk of developing protracted and severe COVID-19, and understanding individual disease courses and SARS-CoV-2 immune responses in these individuals is of the utmost importance. For more than two years, we followed an immunocompromised individual with a pr...
Autores principales: | Bunse, Till, Koerber, Nina, Wintersteller, Hannah, Schneider, Jochen, Graf, Alexander, Radonic, Aleksandar, Thuermer, Andrea, von Kleist, Max, Blum, Helmut, Spinner, Christoph D., Bauer, Tanja, Knolle, Percy A., Protzer, Ulrike, Schulte, Eva C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304262/ https://www.ncbi.nlm.nih.gov/pubmed/37375064 http://dx.doi.org/10.3390/microorganisms11061562 |
Ejemplares similares
-
Antivirale Medikamente: Potente Wirkstoffe, Hoffnungsträger bei COVID‑19 und therapeutische Grenzen
por: Malin, Jakob J., et al.
Publicado: (2022) -
Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”
por: Dioverti, Veronica, et al.
Publicado: (2022) -
Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023) -
Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023) -
Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key?
por: Willimsky, Gerald, et al.
Publicado: (2013)